A Review Of cgmp fda
No. 21 CFR 211.113(a) requires ideal written methods for being proven and adopted during manufacturing to stop objectionable microorganisms in drug solutions not necessary to be sterile. On top of that, the second paragraph of USP Standard Chapter Antimicrobial Effectiveness Tests reads: Antimicrobial preservatives shouldn't be applied as